“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

British Columbia’s Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

The preventative healthcare measures recommended in the Scotland’s Population Health Framework 2025-2035 plan have been ...

New weight management drugs could be used to create a global metabolic health revolution and improve longevity, if investment ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...